Furthermore, our SBT mouse models demonstrate a powerful and complementary approach to traditional transgenics that will allow further dissection of pathological mechanisms of ubiquilin-2 mutants and their role in development of ALS and ALS-dementia. This evidence concerns the gene UBQLN2 and amyotrophic lateral sclerosis.